Both discordant and concordant bone marrow (BM) involvement predict for a poorer outcome independent of the IPI in patients with diffuse large B-cell lymphoma (DLBCL) treated with R-CHOP

被引：0
|
作者：
Sehn, Laurie H. [1 ]
Chhanabhai, Mukesh [2 ]
Singh, Suman [2 ]
Saville, Wayne [3 ]
Matso, Dan [3 ]
Spinelli, John J. [4 ]
Connors, Joseph M. [1 ]
Gascoyne, Randy D. [2 ]
机构：
[1] British Columbia Canc Agcy, Dept Med Oncol, Vancouver, BC, Canada
[2] British Columbia Canc Agcy, Dept Pathol, Vancouver, BC, Canada
[3] Biogen Idec Inc, San Diego, CA USA
[4] British Columbia Canc Agcy, Program Dis Control, Vancouver, BC, Canada
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1559
引用
收藏
页码：466A / 466A
页数：1
相关论文
共 50 条
  • [21] The Hans algorithm is not prognostic in patients with diffuse large B-cell lymphoma treated with R-CHOP
    Castillo, Jorge J.
    Beltran, Brady E.
    Song, Moo-Kon
    Ilic, Ivana
    Leppa, Sirpa
    Nurmi, Heidi
    Seki, Ritsuko
    Uccella, Silvia
    Li, Jun-Min
    Treaba, Diana O.
    Stachurski, Dariusz
    Butera, James N.
    LEUKEMIA RESEARCH, 2012, 36 (04) : 413 - 417
  • [22] Prognostic Impact, Phenotypic and Molecular Characterization of Concordant and Discordant Bone Marrow Involvement in Patients with Diffuse Large b-Cell Lymphoma
    Alonso, Sara
    Alcoceba, Miguel
    Blanco, Oscar
    Davila, Julio
    Carlos Caballero, Juan
    Garcia, Luis
    Ferre, Oscar
    Lopez-Cadenas, Felix
    Arratibel, Nerea
    Veiga, Alvaro
    Baile, Monica
    Lopez, Oriana
    Perez, Estefania
    Dolores Caballero, Maria
    Gonzalez, Marcos
    Del Canizo, Consuelo
    Belen Vidriales, Maria
    Martin, Alejandro
    BLOOD, 2015, 126 (23)
  • [23] THE INTERNATIONAL STAGING SYSTEM PREDICTS OUTCOME IN DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH R-CHOP
    Feng, Ru
    EXPERIMENTAL HEMATOLOGY, 2015, 43 (09) : S62 - S62
  • [24] PROGNOSTIC IMPACT, PHENOTYPIC AND MOLECULAR CHARACTERIZATION OF CONCORDANT AND DISCORDANT BONE MARROW INVOLVEMENT IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
    Alonso, S.
    Alcoceba, M.
    Garcia-Alvarez, M.
    Caballero, J. C.
    Davila, J.
    Blanco, O.
    Caballero, M. D.
    Gonzalez, M.
    Gutierrez, N.
    Martin, A.
    HAEMATOLOGICA, 2016, 101 : 571 - 572
  • [25] Diffuse Large B-Cell Lymphoma (DLBCL) Patients with Composite Histology Have Improved Early outcome Compared to De Novo DLBCL When Treated with R-CHOP
    Maurer, Matthew J.
    Witzig, Thomas E.
    Macon, William R.
    Syrbu, Sergei I.
    Cerhan, James R.
    Allmer, Cristine
    Johnston, Patrick B.
    Link, Brain K.
    Habermann, Thomas M.
    BLOOD, 2008, 112 (11) : 974 - 974
  • [26] Diffuse large B-cell lymphoma: R-CHOP forever?
    Jedrzejczak, Wieslaw W.
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2015, 125 (10): : 713 - 714
  • [27] Prognostic Value of Occult Bone Marrow Involvement Estimated by Immunoglobulin Clonality Assay in Patients with Diffuse Large B-cell Lymphoma Treated with R-CHOP Immunochemotherapy
    Seo, J.
    Hong, J.
    Kim, M.
    Jeong, J.
    Kim, K.
    Ahn, J.
    Park, J.
    Lee, J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (06): : 768 - 768
  • [28] Serum soluble Fas level determines clinical outcome of patients with diffuse large B-cell lymphoma treated with CHOP and R-CHOP
    Takeshi Hara
    Hisashi Tsurumi
    Naoe Goto
    Nobuhiro Kanemura
    Takeshi Yoshikawa
    Senji Kasahara
    Toshiki Yamada
    Michio Sawada
    Hideko Goto
    Kenji Fukuno
    Jun-ichi Kitagawa
    Ichiro Yasuda
    Naoki Katsumura
    Masao Takemura
    Takeshi Takahashi
    Tsuyoshi Takami
    Hisataka Moriwaki
    Journal of Cancer Research and Clinical Oncology, 2009, 135 : 1421 - 1428
  • [29] Serum soluble Fas level determines clinical outcome of patients with diffuse large B-cell lymphoma treated with CHOP and R-CHOP
    Hara, Takeshi
    Tsurumi, Hisashi
    Goto, Naoe
    Kanemura, Nobuhiro
    Yoshikawa, Takeshi
    Kasahara, Senji
    Yamada, Toshiki
    Sawada, Michio
    Goto, Hideko
    Fukuno, Kenji
    Kitagawa, Jun-ichi
    Yasuda, Ichiro
    Katsumura, Naoki
    Takemura, Masao
    Takahashi, Takeshi
    Takami, Tsuyoshi
    Moriwaki, Hisataka
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (10) : 1421 - 1428
  • [30] LYMPHOCYTOPENIA MAY ADD TO THE PREDICTION ACHIEVED BY THE REVISED INTERNATIONAL PROGNOSTIC INDEX (R-IPI) IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) TREATED WITH RITUXIMAB-CHOP (R-CHOP)
    Vassilakopoulos, T.
    Anastasopoulou, A.
    Pangalis, G.
    Constantinou, N.
    Stavroulaki, E.
    Karakatsanis, S.
    Papageorgiou, S.
    Sachanas, S.
    Pappi, V.
    Tsirkinidis, P.
    Moschoyianni, M.
    Kyrtsonis, M.
    Kokoris, S.
    Kalpadakis, C.
    Siakantaris, M.
    Dimou, M.
    Georgiou, G.
    Konstantinidou, P.
    Dervenoulas, J.
    Roussou, P.
    Papadaki, H.
    Panayiotidis, P.
    Beris, P.
    Angelopoulou, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 280 - 280
12345